Flat Capital invests SEK 40 million in Pixelgen Technologies, leads SEK 150 million Series B round

• Flat Capital invested about SEK 40 million in Pixelgen Technologies, leading a Series B funding round of about SEK 150 million.
• Proceeds earmarked for technology development, global commercial expansion of Pixelgen’s single-cell surface protein mapping platform.
• Pixelgen was founded in 2020 in Stockholm; its Proximity Network Assay was commercialized in spring 2025 as the Pixelgen Proxiome Kit.
• Flat Capital CEO Rickard El Tarzi joined Pixelgen’s board in connection with the investment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flat Capital AB published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.